REPOCEUTICALS A/S: Financial statements 2023
CVR: 36494433
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
REPOCEUTICALS A/S (CVR 36494433) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK -5,199,745 compared with DKK -3,828,782 the year before. Equity in the 2023 report amounted to DKK 2,838,441. The solvency ratio was 29.3%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -5,199,745
- Equity
- DKK 2,838,441
- Total Assets
- DKK 9,686,120
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | 0 | -5.2M | 2.8M | - |
| 2022 | 0 | 0 | -3.8M | 8.3M | - |
| 2021 | 0 | 0 | -4.4M | 12M | - |
| 2020 | 0 | 0 | -859K | 5.2M | - |
| 2019 | 0 | 0 | -523K | 6M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
REPOCEUTICALS A/S has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -3,828,782.
As of May 24, 2023, Nete Søgaard Poulsen has left the board of directors of REPOCEUTICALS A/S.
About REPOCEUTICALS A/S
REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.